According to Leap Therapeutics 's latest financial reports the company's current EPS (TTM) is -$6.51. In 2022 the company made an earnings per share (EPS) of -$4.80 a decrease over its 2021 EPS that were of -$4.80.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$6.51 | 35.63% |
2022 | -$4.80 | 0% |
2021 | -$4.80 | -43.53% |
2020 | -$8.50 | -43.33% |
2019 | -$15.00 | -11.73% |
2018 | -$16.99 | -51.03% |
2017 | -$34.70 | 131.23% |
2016 | -$15.01 | 138.67% |
2015 | -$6.29 | -66.83% |
2014 | -$18.96 | -22.86% |
2013 | -$24.57 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | -$2.18 | -66.51% | ๐บ๐ธ USA |